Clinical characteristics and antibody response to Omicron variants among solid carcinoma patients in China on the 2022.12–2023.4 wave of the COVID-19 pandemic
This study elucidated the clinical and immunological characteristics of SCPs during the Omicron wave in China after the shift away from a zero-COVID-19 policy. Our findings provide insights regarding factors that influence COVID-19 symptoms and antibody levels in this population.
Authors
- Qin Pan (ORCID: https://orcid.org/0000-0001-5855-4952)
- Fang He (ORCID: https://orcid.org/0000-0002-5938-004X)
- Hangjie Zhang (ORCID: https://orcid.org/0000-0001-7334-2536)
- Nani Xu
- Qianhui Hua
- Weiyu Peng (ORCID: https://orcid.org/0000-0001-7069-9556)
- Jianmin Jiang (ORCID: https://orcid.org/0000-0002-3271-1662)
- Rongrong Dai
- Linling Ding
Institutions
- Hangzhou Center for Disease Control and Prevention (CN)
- Shenzhen Center for Disease Control and Prevention (CN)
- Zhejiang Provincial People's Hospital (CN)
- Zhejiang Center for Disease Control and Prevention (CN)
- Hangzhou Medical College (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-11-06
- DOI
- https://doi.org/10.3389/fimmu.2024.1476186
- Citations
- 1
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- National Health Commission of the People's Republic of China